Mariner, LLC Grifols Sa Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Grifols Sa stock. As of the latest transaction made, Mariner, LLC holds 24,766 shares of GRFS stock, worth $215,464. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,766

Previous 17,581 40.87%

Holding current value

$215,464

Previous $110,000 99.09%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.28 - $9.38 $45,121 - $67,395	7,185 Added 40.87%	24,766 $219,000
Q2 2024 Aug 13, 2024	BUY	$6.27 - $7.7 $23,719 - $29,129	3,783 Added 27.42%	17,581 $110,000
Q1 2024 May 15, 2024	SELL	$5.47 - $11.38 $120,181 - $250,029	-21,971 Reduced 61.42%	13,798 $92,000
Q4 2023 Feb 14, 2024	SELL	$7.71 - $11.56 $6,044 - $9,063	-784 Reduced 2.14%	35,769 $413,000
Q3 2023 Nov 13, 2023	BUY	$8.91 - $10.91 $21,918 - $26,838	2,460 Added 7.22%	36,553 $334,000
Q2 2023 Aug 11, 2023	BUY	$7.14 - $9.29 $52,657 - $68,513	7,375 Added 27.6%	34,093 $312,000
Q1 2023 May 12, 2023	BUY	$6.65 - $10.69 $61,366 - $98,647	9,228 Added 52.76%	26,718 $197,000
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.53 $10,036 - $14,364	1,684 Added 10.65%	17,490 $149,000
Q3 2022 Nov 10, 2022	BUY	$5.95 - $14.3 $94,045 - $226,025	15,806 New	15,806 $97,000
Q1 2021 May 07, 2021	SELL	$15.15 - $19.78 $603,894 - $788,450	-39,861 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$16.86 - $19.67 $672,056 - $784,065	39,861 New	39,861 $735,000
Q4 2019 Feb 13, 2020	SELL	$19.57 - $23.52 $448,603 - $539,148	-22,923 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$19.85 - $22.76 $16,296 - $18,685	-821 Reduced 3.46%	22,923 $459,000
Q2 2019 Aug 14, 2019	SELL	$17.59 - $21.1 $11,785 - $14,137	-670 Reduced 2.74%	23,744 $501,000
Q1 2019 May 15, 2019	BUY	$18.01 - $20.11 $439,696 - $490,965	24,414 New	24,414 $491,000

Others Institutions Holding GRFS

# of Institutions

162

Shares Held

140M

Call Options Held

288K

Put Options Held

389K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.91B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account